Comparative study of patient will recieve retrolaminar block with patient will not receive retrolaminar block in adult patient undergoing percutaneous nephrolithotomy surgery

Comparative study of analgesic effectiveness in Retrolaminar block with intravenous patient controlled analgesia (PCA) in adult patients undergoing percutaneous nephrolithotomy surgery : A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/049220

Enrollment

Registered

2023-01-25

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N201- Calculus of ureter Health Condition 2: N289- Disorder of kidney and ureter, unspecified Health Condition 3: O- Medical and Surgical Health Condition 4: N29- Other disorders of kidney and ureter in diseases classified elsewhere Health Condition 5: N288- Other specified disorders of kidney and ureter

Interventions

Intervention1: general anesthesia with retrolaminar block: 0.25% bupivacaine of total volume 20 ml while intraoperative period Control Intervention1: Group II : Patient will receive general anesthesi

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 70 (Either sex) ASA I/II BMI <30kg/m2

Exclusion criteria

Exclusion criteria: History of focal neurological deficit psychiatric disorder coagulation disorder liver pathology use of any opioid in last 6 month

Design outcomes

Secondary

Measure	Time frame
Time of first rescue analgesia NRS score at post operative periodTimepoint: NRS score postoperative at 30 min,2 hour,4 hour,8 hour,12 hour,24 hour	—

Primary

Measure	Time frame
To measure perioperative fentanyl consumption in 24 hoursTimepoint: To measure perioperative fentanyl consumption in 24 hours	—

Countries

India

Contacts

Public ContactAnu Kumari

All india institute of medical science patna

drpoonam1981@gmail.com7992418189

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026